Elanco Technology Acquisitions

Company Background

Elanco is a division of Eli Lilly and Company, a recognized leader in the human pharmaceutical arena since 1876. Elanco is a global research-based company with over 2,000 employees dedicated to developing products to improve the health of animals which we market in more than 75 countries.

Elanco has world-class resources and a strong track record of bringing innovation to the global market. Core competencies include: research and product development, manufacturing, regulatory expertise, marketing and a top-flight sales force.

The Preferred Partner for Animal Health Innovations

Elanco is committed to being the preferred partner for delivering innovative solutions to the veterinary market. Elanco is strongly committed to building partnerships based on mutual trust, respect, and integrity. We recognize both partners possess valuable assets, and both have a mutual desire to optimize the market value of those assets.